Pharmaceutical industry – Page 30
-
Business
FDA urges labs to test all blood donations for Zika
Agency has also given emergency authorisation to two new Zika blood tests
-
Business
Pfizer to buy Astrazeneca’s antibiotics
Deal tops up Pfizer’s late-stage development pipeline, but AZ will retain biological programmes
-
Business
Pfizer gambles on $14bn Medivation deal
Cancer specialist likely just one target in hunt for marketed drugs to offset patent expiries
-
Opinion
Preparing for the future of pharma
Dave Allen discusses how scenario planning helps to define uncertainty in pharma
-
Business
Standard antibody will bolster biopharma
New NIST reference material will help validate and compare analytical techniques
-
Business
Amgen and Advaxis partner on immuno-oncology
Deal covers rights to system for building cancer therapies specific to a patient’s own tumours
-
Business
Job cuts at Takeda, Boehringer and Arena
Hundreds of positions eliminated as companies re-evaluate R&D
-
Business
Celgene and Jounce team up against cancer
Firms promise next-generation immuno-oncology as existing drugs rack up successes
-
Business
Juno CAR-T trial suspended after patient deaths
Immunotherapy study restarted with amended pre-treatment protocol
-
Opinion
Time for better incentives to keep drug costs low
Getting outraged at drug price hikes is all very well, but we need more constructive options
-
Business
All part of the service
Simon Hirst, founder of contract research organisation Sygnature, is the 2016 Chemistry World entrepreneur of the year
-
Business
Unpicking doctor payments
Accepting even small meals from drug industry reps appears to influence doctors’ prescription rates
-
Business
AstraZeneca licenses skin drugs to Leo
Offloading psoriasis and dermatitis antibodies continues AZ’s plan to refocus on fewer therapy areas
-
Business
Novartis partners with Xencor for cancer antibodies
Deal deepens Novartis’s focus on immuno-oncology
-
Business
Lies and deception see Astellas UK suspended by trade body
Company promoted drugs inappropriately and misled regulators in the resulting investigation
-
Business
Sanofi and Boehringer agree €11bn asset swap
Deal swaps Sanofi’s animal health arm for Boehringer’s consumer healthcare business as both firms aim to boost scale
-
Business
Harvard settles with ex-student over drug royalties
Student claimed university forced him to accept unfair cut in patent deal
-
Business
Teva sells off products in preparation for Allergan merger
Generics deals with Impax, Dr Reddy’s and Sagent aimed at satisfying competition authorities
-
Business
US biotech director accused of insider trading
Biostatistics chief at Akebia charged with securities fraud